Mina L Xu
@MinaXu7
Followers
1K
Following
2K
Media
64
Statuses
534
Physician, Professor of Pathology at Yale University School of Medicine, Director of Hematopathology, (tweets/retweets are not medical advice)
Yale University
Joined March 2016
RT @TrowbridgeLab: We had the honor to preview @TheKingLab's new publication in @CellStemCell; 'Plot Twist: TET2 Clones Save the Brain'. If….
0
10
0
Congratulations @Miao__Liu and the whole team!.
Excited to share our latest paper in @NatureGenet with @SStevenWang on the evolution of 3D genome organization in 🐁 models of #LungCancer and #PancreaticCancer. Kudos to @Miao__Liu @SherrySu1! @YaleGenetics @YaleCancer @CancerYale
0
1
7
Although many use PAX5 IHC in these situations, here we show the sensitivity and specificity on a range of shady B-ALLs and MPALs. Also looked at metrics for OCT2 and BOB.1, which are less reliable.
1
0
3
So proud of hemepath fellow-to-be @Ernest0995 for publishing this multicenter study establishing diagnostic utility of PAX5 in difficult B-ALLs. Huge thanks to collaborators including @weinberg_olga and @ZenggangPan #hemepath.
2
7
30
Congratulations Peng, on this cool study!.
Delighted to share our recently published work on the role of DDX41 in resolving G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death. @NatureComms
0
0
14
Absolutely love these: .10-Minute Challenge: Bosch’s ‘Garden of Earthly Delights’ via @NYTimes.
nytimes.com
We’d like you to look at one piece of art for 10 minutes, uninterrupted.
0
4
11
RT @DrChrisHourigan: So it turns out, yet again, that actually doing stuff, not just talking about the way the world should be, is hard. ht….
0
5
0
RT @sanamloghavi: Our CME-accredited course “Implementing Comprehensive Genomic Profiling Into Your Oncology Care Plan” is now available o….
0
4
0
RT @sanamloghavi: Out today in @LeukemiaJnl .Our study of Erythroid-predominant MDS with distinct genotypes and associated with prognosti….
nature.com
Leukemia - Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy
0
16
0
Congratulations @Savanaplastic and @ZenggangPan on leading our team and getting the word out on the dynamics of lymphomatous effusions in large B-cell lymphomas #hemepath
pubmed.ncbi.nlm.nih.gov
The pathologic features of SE-LBCL were similar to those of solid-only LBCL but distinct from those of EB-LBCL; in particular, lymphomatous effusion was an independently adverse prognostic factor in...
1
8
18
RT @sanamloghavi: It finally here 🥳. If you’re like us & your (professional) 🌍 revolves around myeloid neoplasms w….
aacrjournals.org
AbstractThe World Health Organization fifth edition and International Consensus Classification for myeloid neoplasms both incorporate empirical numerical thresholds to morphologic and molecular...
0
10
0
RT @Zhiliang_Bai: We are looking for talented postdocs/visiting students to join our team @MITdeptofBE and @kochinstitute to innovate spati….
0
57
0
RT @Dr_AmerZeidan: We are looking for an experienced clinical researcher specialized in lymphoma to join our division of hematologic malign….
0
24
0
